Pantoprazole Sodium Tablet, Delayed Release
NDC Package 51407-613-90
Package Information
Pantoprazole Sodium tablets is pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). This formulation utilizes a tablet, delayed release delivery system. Marketed by Golden State Medical Supply, Inc., this product is identified by NDC 51407-613 and is authorized under FDA application ANDA078281.
Identification & Billing
- RxCUI: 251872 - pantoprazole sodium 20 MG Delayed Release Oral Tablet
- RxCUI: 251872 - pantoprazole 20 MG Delayed Release Oral Tablet
- RxCUI: 251872 - pantoprazole 20 MG (as pantoprazole sodium sesquihydrate 22.56 MG) Delayed Release Oral Tablet
- RxCUI: 314200 - pantoprazole sodium 40 MG Delayed Release Oral Tablet
- RxCUI: 314200 - pantoprazole 40 MG Delayed Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51407 - Golden State Medical Supply, Inc.
- 51407-613 - Pantoprazole Sodium
- 51407-613-90 - 90 TABLET, DELAYED RELEASE in 1 BOTTLE
- 51407-613 - Pantoprazole Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51407-613). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51407-613-90 identifies a specific commercial package of 90 tablet, delayed release in 1 bottle of Pantoprazole Sodium, a human prescription drug labeled by Golden State Medical Supply, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This tablet, delayed release is formulated for oral use and contains pantoprazole sodium as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Golden State Medical Supply, Inc. on January 20, 2011. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and persistent cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs).
How is this Golden State Medical Supply, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51407061390. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.